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Abstract During host–pathogen interactions, a complex web of events is crucial
for the outcome of infection. Pathogen recognition triggers powerful cellular
signaling events that is translated into the induction and maintenance of innate
and adaptive host immunity against infection. In opposition, pathogens employ
active mechanisms to manipulate host cell regulatory pathways toward their pro-
liferation and survival. Among these, subversion of host cell energy metabolism by
pathogens is currently recognized to play an important role in microbial growth and
persistence. Extensive studies have documented the role of AMP-activated protein
kinase (AMPK) signaling, a central cellular hub involved in the regulation of
energy homeostasis, in host–pathogen interactions. Here, we highlight the most
recent advances detailing how pathogens hijack cellular metabolism by suppressing
or increasing the activity of the host energy sensor AMPK. We also address the role
of lower eukaryote AMPK orthologues in the adaptive process to the host micro-
environment and their contribution for pathogen survival, differentiation, and
growth. Finally, we review the effects of pharmacological or genetic AMPK
modulation on pathogen growth and persistence.
Keywords SNF1/AMPK • Host-pathogen interactions • Infection • Metabolism •
Microbial auxotrophy • Bioenergetics
12.1 Introduction
Adenosine 50 monophosphate‐activated protein kinase (AMPK) is a heterotrimeric
serine/threonine kinase consisting of a catalytic subunit (α) and two regulatory
subunits (β and γ) (Xiao et al. 2011). AMPK is considered a pivotal regulator of
cellular metabolism known as a metabolic “master regulator,” switching on cata-
bolic pathways that generate ATP, while switching off anabolic pathways that
consume ATP. Therefore, upon activation, AMPK downregulates several anabolic
enzymes through phosphorylation leading to the inhibition of both translation
initiation by restraining mammalian target of rapamycin complex 1 (mTORC1)
activity, as well as translation elongation through the inactivation of Eukaryotic
Elongation Factor 2 (eEF2), which will ultimately decrease cellular ATP con-
sumption. In opposition, AMPK activates a catabolic state by inducing oxidative
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pathways generating energy through the activation of glucose uptake (via activa-
tion of both glucose transporter 1 (GLUT1) and GLUT4) (Barnes et al. 2002;
Holmes et al. 1999), glycolysis (via phosphorylation and activation of two of four
isoforms of 6-phosphofructo-2-kinase) (Marsin et al. 2002), fatty acid uptake (via
translocation of the fatty acid transporter FAT/CD36) (Bonen et al. 2007), and
fatty acid oxidation (via phosphorylation of the isoform 2 of acetyl-CoA carbox-
ylase (ACC2)) (Winder and Hardie 1996). Classically, the canonical upstream
activator that phosphorylates AMPK on Thr 172 (Stein et al. 2000) is the consti-
tutively active tumor suppressor liver kinase B1 (LKB1) accompanied by two
accessory subunits, sterile 20 protein‐related adaptor (STRAD) and mouse protein
25 (MO25) (Hawley et al. 2003; Woods et al. 2003), but additional activators such
as the Ca2+-calmodulin-dependent kinase kinase (CaMKK) has been also identi-
fied (Woods et al. 2005; Hawley et al. 2005).
AMPK is capable of sensing changes in the energy status of the cell, and
therefore it is not surprising that it plays a pivotal role during infections (Moreira
et al. 2015b). Nutritional immunity has been described as a defence mechanism
employed by host cells to prevent the acquisition of essential nutrients by intracel-
lular pathogens, thus preventing pathogen scavenging and further utilization for
replication and survival (Hood and Skaar 2012). Furthermore, recent advances have
underlined the role of AMPK in macrophage, T cell, and DC functions in distinct
settings, providing a molecular link between bioenergetics homeostasis, viability,
and effector functions of adaptive and innate immune cells (Blagih et al. 2015;
Kelly and O’Neill 2015; Yang and Chi 2015). These concepts are the core of host–
pathogen dynamics. Herein, we review the contribution of AMPK sensor in regu-
lating viral, bacterial, parasitic, and fungal infections. Furthermore, given the high
degree of conservation among eukaryotes, we intend to discuss the crucial role of
AMPK in parasites and fungi. The most recent findings concerning the AMPK role
in the parasite and fungal biology during host–pathogen interaction will be also
addressed.
12.2 AMPK: A Regulator in Viral Infection
12.2.1 Modulation of AMPK Activity by Viruses
Simian virus 40 (SV40) is a polyoma virus that encodes for small and large T
antigens implicated in tumor formation. SV40 small T antigen has been shown to
protect human cells in glucose deprivation. This survival advantage for cancer cells
was demonstrated to be correlated with an increased phosphorylation of AMPK and
consequent downregulation of mTORC1, which ultimately triggered autophagy
(Kumar and Rangarajan 2009). In vitro infection with avian reovirus (ARV)
resulted in an increase in AMPK phosphorylation on Thr172 (Ji et al. 2009) and a
concomitant increase in mitogen-activated protein kinase (MAPK) p38
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phosphorylation. AMPK phosphorylation has also been described to be increased
early after infection with Rift Valley fever virus (RVFV), an important reemerging
arthropod-borne human pathogen (Moser et al. 2012).
On the contrary, infections with Hepatitis C virus (HCV), Human cytomegalo-
virus (HCMV), Herpes simplex virus (HSV), Epstein–Barr virus (EBV), and human
immunodeficiency virus-1 (HIV-1) have been reported to inhibit AMPK activity. In
this context, cells infected with HCV or harboring an HCV subgenomic replicon
inhibited the phosphorylation of AMPK at Thr172. This was consistent with the
concomitant reduction on AMPK activity and increased hepatic lipid accumulation
required for virus replication (Mankouri et al. 2010). Inhibition of Thr172 phos-
phorylation was associated with an increased phosphorylation of AMPK at an
alternative site, Ser485, which is phosphorylated by protein kinase B (PKB/Akt)
(Horman et al. 2006). Interestingly, both HCV NS4B and NS5A proteins have been
shown to activate the protein kinase AKT (Park et al. 2009; Street et al. 2004). In
addition to HCV, HCMV, a beta herpes virus that establishes chronic infections,
activates mTOR signaling by inhibiting AMPK Thr172 phosphorylation at early
time points postinfection (Kudchodkar et al. 2007). Interestingly, at later time
points of infection, a kinome RNAi screen performed in HCMV-infected MRC5
fibroblasts identified 106 cellular kinases that influenced the growth of the virus,
including multiple elements of the AMPK pathway (Terry et al. 2012). The effector
proteins responsible for the AMPK inhibition still remain elusive, although the
inhibition of CaMKK was reported to block HCMV-mediated AMPK activation
(McArdle et al. 2011, 2012). Furthermore, it has been shown that HCMV blocked
the function of the mitochondrial trifunctional protein (TFP), a key enzyme during
fatty acid-β-oxidation (Seo and Cresswell 2013), through the redistribution of
viperin to the mitochondria. The resulting decrease in cellular ATP levels and
consequent increase in AMP-activated AMPK. The latent membrane protein
1 (LMP1) encoded by EBV, which is associated with the development of nasopha-
ryngeal carcinoma, inhibited the phosphorylation of LKB1 at serine 428 leading to
the inhibition of AMPK phosphorylation (Plummer et al. 2013).
Sirtuin 1 (SIRT1), a nicotinamide adenine dinucleotide-dependent class III
protein deacetylase, and AMPK are activated during the cellular response to
nutrient deprivation and exhibit a reciprocal regulation (Fulco et al. 2008). In the
context of HCV core protein expression in HepG2 cells, it has been shown that the
activity of SIRT1 along with AMPK is decreased (Yu et al. 2013). In the context of
HIV infection, it has been proposed that the transactivator Tat protein mediates its
effect on AMPK via the inhibition of SIRT1 (Zhang and Wu 2009). However, a
certain complexity is associated with the fact that SIRT1 deacetylates Tat (Pagans
et al. 2005) and Tat inhibits SIRT1 (Kwon et al. 2008). More recently, it has been
proposed that curcumin reversed Tat-mediated reduction in AMPK activation and
downstream ACC activation (Zhang et al. 2011). Therefore, the relationship
between HIV infection and AMPK modulation merits to be further explored in
the context of viral infection.
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12.2.2 Role of AMPK in Virus Entry and Replication
Since some viruses manipulate host AMPK toward immune evasion, a valuable
therapeutic antiviral strategy may pass through the pharmacological manipulation
of AMPK activity. In this context, Vaccinia virus infects a wide range of host cells,
and all three subunits of AMPK facilitated virus entry (Moser et al. 2010). AMPK is
involved in poxvirus entry in a manner that is independent of its role as a metabolic
regulator. The authors point to a novel role of AMPK in promoting
macropinocytosis and cellular motility by regulating actin dynamics, independently
of LKB1 or CaMKK (Moser et al. 2010). AMPK deficiency attenuated vaccinia
infection by interfering with viral entry. This supports the development of selective
AMPK inhibitors or other inhibitors of macropinocytosis against poxviruses, as
well as for other viruses that hijack this endocytic route for their entry mechanism.
In vitro treatment of hepatoma cells with the AMPK activator 5-aminoimidazole-4-
carboxamide 1-β-D-ribofuranoside (AICAR) was shown to suppress HCV replica-
tion (Nakashima et al. 2011; Mankouri et al. 2010). The importance of AMPK in
HCMV replication is supported by the observation that the inhibition of AMPK
kinase with compound C attenuates early and late HCMV replication (Hutterer
et al. 2013; McArdle et al. 2012; Terry et al. 2012). Moreover, the addition of
2-octynoic acid (2-OA) to HCV-infected cells inhibited viral replication in a
process involving the activation of AMPK and the inhibition of ACC, the first
rate-limiting enzyme in fatty acid synthesis (Yang et al. 2013). Importantly, it has
been shown that AMPK and its upstream activator LKB1 are essential for the
control of RVFV infection, which is associated with the phosphorylation and
inhibition of ACC. Treatment with the fatty acid palmitate bypasses this restriction,
demonstrating that AMPK restricts RVFV infection through its inhibition of fatty
acid biosynthesis (Moser et al. 2012). Furthermore, the authors showed that AMPK
restricts the growth of multiple arboviruses from disparate families, including the
Flavivirus Kunjin virus (KUNV), the Togavirus Sindbis virus (SINV), and the
Rhabdovirus Vesicular stomatitis virus (VSV) (Moser et al. 2012). Therefore, this
process represents a novel mechanism of interest regarding viruses’ control mech-
anisms. Because many viruses require complex and unique interactions with cel-
lular lipid metabolism through both synthesis and degradation pathways, it cannot
be excluded that viruses inhibit AMPK activation in order to stimulate lipid
synthesis within the infected cells. Thus, AMPK activation is broadly antiviral
and may provide a novel antiviral therapeutic target.
Finally, it has been proposed that AMPK is involved in the reactivation of latent
viruses, such as HIV-1, through bryostatin-induced activation, a protein kinase C
activator (Mehla et al. 2010). This was further confirmed by the use of compound C
that partially reduced HIV-1 reactivation. In the same study, the authors showed
that metformin, an oral antidiabetic drug that activates AMPK indirectly through
mitochondrial complex I inhibition (Zhou et al. 2001), inhibits HIV-1 replication.
These results underline differential effects either on the reactivation of HIV-1 or the
productive viral replication (Mehla et al. 2010). Furthermore, metformin also
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inhibits in vitro HCV replication (Huang et al. 2013). The addition of metformin to
current HCV treatment regimens had promising, albeit modest, effects on reducing
patient viral loads (Romero-Gomez et al. 2009). Moreover, several AMPK activat-
ing drugs have been shown to reduce morbidity and mortality during lethal influ-
enza infection in mice (Moseley et al. 2010).
12.2.3 AMPK and Autophagy During Viral Infections
Autophagy becomes particularly important during cellular starvation as a means to
recycle amino acids and cellular components for use as catabolic fuels. mTOR
forms two functionally distinct complexes in mammals, mTORC1 and mTORC2.
In particular, mTORC1 senses nutrient deprival. This is an essential information to
take into account when addressing host–pathogen interactions, given that AMPK is
an established negative regulator of the mTOR signaling cascade (Inoki et al. 2003;
Shaw et al. 2004). AMPK can directly phosphorylate Raptor, a positive regulatory
subunit of the mTORC1 complex, and, in addition, it has been shown that AMPK
phosphorylates the protein kinase UNC-51-like kinase 1 (ULK1), which is a key
signaling complex required for autophagosome formation (Egan et al. 2011; Kim
et al. 2011). During the last two decades, autophagy has been analyzed more in
detail and described to regulate host–pathogen interactions. Growing evidences
indicate that autophagy acts both in the antiviral and proviral pathway (Rey-Jurado
et al. 2015; Santarelli et al. 2015) Viral infections may result in the inhibition of
host cell metabolism, thus leading to a concomitant reduction in energy demands.
This could happen either by blocking host cell protein synthesis, while in the
opposite way, by placing increased energetic demands upon infection, which
might result in an activation of AMPK. Further studies are necessary to assess the
contributing role of the AMPK pathway in regulating autophagy in the context of
viral infections. Therefore, it cannot be excluded that AMPK is a critical regulator
of cell autophagy in the context of host–pathogen interactions that need to be
further addressed.
12.2.4 AMPK and Immune Effector Functions Cells During
Viral Infection
Immune response against pathogens and in particular viruses leads to a rapid
modification of cellular metabolism. It has been initially identified that signal
transduction pathways, which modulate T-cell metabolism, involve LKB1 and
AMPK as key regulators (Blagih et al. 2015; Blagih et al. 2012). Thus, LKB1-
deficient T cells exhibited defects in cell proliferation and viability, accompanied
by altered glycolytic and lipid metabolism. Interestingly, loss of LKB1 promoted an
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increase in T cell activation and inflammatory cytokine production by both CD4+
and CD8+ T cells (MacIver et al. 2011). However, although AMPKα1 activity is
dispensable for proliferation and differentiation of cytotoxic T lymphocytes
(CTLs), AMPK knockout (KO) mice show a striking defect in their ability to
generate memory CD8+ T-cell responses in vivo, along with a lower survival of
CTLs following withdrawal of immune stimulation (Rolf et al. 2013). The role of
metformin has also been addressed in arthritis. It was recently shown that the
attenuation of the disease in AMPK KO mice could result from decreased levels
of pro-inflammatory cytokines. Interestingly, the impact of AMPK on the differen-
tiation of T cells into T helper 17 (Th17) cells upon stimulation was also demon-
strated (Kang et al. 2013). Recently, it has been demonstrated that AMPKα1 is
essential for Th1 and Th17 cell development and primary T cell responses to viral
and bacterial infections. A reduction of both Th1 and Th17 responses (Estaquier
et al. 1996; Estaquier et al. 1995; Raffatellu et al. 2008; Brenchley et al. 2008;
Cecchinato et al. 2008; Campillo-Gimenez et al. 2010) were associated with a
higher propensity of the cells to die by apoptosis observed during the course of
HIV-1 infection (Estaquier et al. 1994; Monceaux et al. 2003; Hurtrel et al. 2005;
Cumont et al. 2007). This originates the question as whether or not metformin could
restore functional immune effector T cells through AMPK activation and if this
approach could have potential interest in the development of therapeutic strategy
against acquired immunodeficiency syndrome (AIDS). Thus, given the critical role
played by CD4+ and CD8+ T cells in controlling viruses, regulation of metabolic
homeostasis represents a quite remarkable field to explore in the context T cell
immunity.
In addition to adaptive immunity, a role for AMPK in regulating innate immu-
nity has been proposed. AMPK activation promotes macrophage polarization
toward an anti-inflammatory M2 phenotype (Sag et al. 2008) and modulates
inflammatory gene expression through activation of SIRT1 (Yang et al. 2010b).
However, one important effect of AMPK is the suppression of signal transducers
and activators of transcription 1 (STAT1) signaling induced by interferon-gamma
(IFN-γ), which inhibits inflammation and chemokines in primary astrocytes and
microglia (Meares et al. 2013). This could be particularly important in the context
of neuronal infections because inflammation in the central nervous system contrib-
utes to neurologic disorders. Furthermore, type I IFN-derived immune responses,
which are essential for controlling virus spread, decreases the phosphorylation of
AMPK. Consistently, metformin enhances the antiviral effect of IFN-β in
Coxsackievirus B3 virus infection (Burke et al. 2014). It has been also proposed
that 2-OA antiviral activity against HCV is associated with AMPK activation,
through induction of interferon stimulated genes (ISGs) and the inhibition of
miR-122 expression (Yang et al. 2013). In the context of RVFV, however, the
authors have excluded a role of type I IFN in regulating virus infection downstream
AMPK (Moser et al. 2012). Therefore, AMPK appears to be a central player in
regulating innate and adaptive immune responses, which are essential in controlling
viral infections. Figure 12.1 illustrates the differential regulation of AMPK activity
by viruses.
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12.3 AMPK in the Control of Bacterial Infection
Pathogenic intracellular bacteria infect their hosts by exploiting its cytoplasmic
milieu toward survival, growth, and dissemination. During infection, intracellular
bacteria must compete with the host in order to obtain the necessary energy and
carbon sources. The specific scavenge of nutritional sources by the bacteria may
increase their survival odds and consequently can be detrimental to the survival of
the permissive host. In parallel, the host cell is forced to respond vigorously to the
internal threat by using specific microbicidal mechanisms at the same time that
need to maintain bioenergetic homeostatic levels to prevent failure and death. Yet,
AMPK beneficial or prejudicial role during bacterial infections appears to be
pathogen-specific (Fig. 12.2).
Fig. 12.1 Viral infection induces a differential regulation of AMPK activity. Host AMPK may be
modulated in order to promote and ease virus entry (e.g., by macropinocytosis) and immune evasion.
AMPK modulation results in the activation of several downstream targets and consequent host
metabolism reprograming. Catabolic processes, as fatty acid oxidation and glucose metabolism, are
activated through phosphorylation of ACC and increased expression of GLUT4, respectively. On
the other side, anabolic processes, as protein synthesis and fatty acid synthesis, are inhibited.
NAMPT-induced activation of SIRT1 originates increased PGC1α-induced transcription of mito-
chondrial genes. Mitophagy may also be induced by AMPK activation, although its role in viral
infections has yet to be addressed. ACC acetyl-coA carboxylase, AMPK AMP-activated protein
kinase, CaMKKβ calcium/calmodulin-dependent protein kinase kinase β, GLUT4 glucose trans-
porter 4, NAD nicotinamide adenine dinucleotide, Nampt nicotinamide phosphoribosyltransferase,
MKK3/6 MAPK kinase 3/6, mTOR mechanistic target of rapamycin, LKB1 liver kinase B1, p38
MAPK p38 mitogen-activated protein kinase, PGC1α peroxisome proliferator-activated receptor γ
co-activator-1α, SIRT1 Sirtuin 1, TSC tuberous sclerosis, ULK1 Unc-51-like kinase 1
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Fig. 12.2 AMPK signaling pathways during host response to bacterial infection. The release of
bacterial products such as TLR agonists and PFT or the infectious process itself may lead to
AMPK activation. This occurs through alteration of the intracellular calcium concentration and
consequent CAMKKβ activation, decrease of ATP/AMP ratios, or ROS production. Additionally,
AMPK may also be activated by chemical compounds such as AICAR, metformin, and
compound. The phosphorylation of AMPK in the threonine residue 172 (Thr172) during bacterial
infections has multiple effects in energy metabolism and autophagy that ultimately contribute to
the resolution or progression of the infection. AMPK is a negative regulator of mTOR, so, upon
Thr172 phosphorylation, mTOR is inhibited, as well as protein synthesis. Furthermore, mitochon-
drial metabolism is impacted during infection: mitochondrial respiration and biogenesis may be
indirectly increased during bacterial-induced AMPK activation. Furthermore, the transcriptional
co-activator PGC-1α is directly modulated by AMPK and originates the increase in transcription
of autophagy-related genes, thus leading to increased xenophagy. However, the role of xenophagy
in the disclosure of a bacterial infection is still controversial. On one hand, this antibacterial
process may cause bacterial death and elimination, through acidification of the intracellular niches
and consequent degradation of pathogen. On the other hand, it may increase nutrient availability,
thus contributing to pathogen survival. Similarly, the increase in mitochondrial mass may cause an
increase in lipid oxidation, which contributes to increased intracellular nutrient availability and,
consequently, to proliferation and survival of the pathogen. AICAR 5-aminoimidazole-4-
carboxamide-1-β-D-ribofuranoside, AMP adenosine monophosphate, AMPK AMP-activated pro-
tein kinase, ATP adenosine triphosphate, CaMKKβ calcium/calmodulin-dependent protein kinase
kinase β, mTOR mechanistic target of rapamycin, PFT pore-forming toxins, PGC1α peroxisome
proliferator-activated receptor γ co-activator-1α, ROS reactive species of oxygen, TLR Toll-like
receptor
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12.3.1 Autophagy: Is Self-Eating Saving or Killing
the Bacteria?
Such as in the context of viral infections, it has been shown that selective recogni-
tion of intracellular bacteria and their targeting to the autophagic machinery for
degradation in lysosomes, also referred as xenophagy, is of crucial importance for
bacterial control (Cemma and Brumell 2012). Xenophagy has been put forward as a
key component of cell-autonomous innate immunity defence mechanisms against
infections (Sorbara and Girardin 2015). If in one hand, xenophagy may contribute
to pathogen elimination, in the other, it may also provide the necessary intracellular
metabolites that sustain pathogen growth. Amino acid (AA) starvation induced by
bacterial pathogens is sensed by the host to trigger protective innate immune and
stress responses. The bacteria Shigella and Salmonella are able to trigger an acute
AA starvation in HeLa cells, as a consequence of host membrane remodeling and
damage. Thus, the AA depletion led to the inhibition of the mTOR pathway
emphasizing a possible activation of AMPK (Tattoli et al. 2012). Francisella
tularensis is an example of a cytosolic bacterium that activates host autophagic
system to increase cytosolic pools of nutrients for its own advantage (Steele
et al. 2013). On the other hand, bacterial pathogens have suffered selective pressure
leading to the acquisition of skills to manipulate the host enzymatic machinery in
their own advantage. In this sense, bacteria can not only prevent the initiation of
autophagic mechanisms and maturation of phagosomes, but they are also able to
use some components of xenophagy toward its replication and survival (Levine
et al. 2011; Deretic et al. 2013). Mycobacterium tuberculosis (Mtb) and Yersinia
pseudotuberculosis represent well this last group. Y. pseudotuberculosis can repli-
cate inside autophagosomes, which are blocked in their maturation and thus unable
to fuse with lysosomes (Moreau et al. 2010). M. tuberculosis is capable of evading
autophagy in macrophages through the inhibition of xenophagic pathways (Kumar
et al. 2010). In this case, treatment with Isoniazid, a first-line drug against tuber-
culosis, during the first 24 h of infection is capable to restore autophagy in
M. tuberculosis-infected bone marrow-derived macrophages (BMDMs) in an
AMPK-dependent manner leading to pathogen elimination (Kim et al. 2012).
Nonetheless, the replenishment of essential substrates for the pathogen may be
assured through modulation of AMPK activity (Brunton et al. 2013). Mycobacte-
rium tuberculosis is capable of utilizing fatty acids as the major energy source
(Rhee et al. 2011). While fatty acids and cholesterol are viewed as the predominant
carbon source throughout infection (Lee et al. 2013; McKinney et al. 2000; Munoz-
Elias and McKinney 2005; Pandey and Sassetti 2008), triglycerides could represent
an energetic reservoir during bacteria dormancy (Daniel et al. 2004).
M. tuberculosis is capable of inhibiting AMPK and activating mTOR by inducing
lipid synthesis. It was recently shown that Mtb accumulated intracellular
triacylglycerides (TAG) whose composition is nearly identical to host TAG.
Accordingly, it was demonstrated that Mtb TAG were synthesized using free
fatty acids released from host macrophages. This lipid scavenging created an
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energetic reservoir that ultimately allows the bacteria to enter in a latent stage
(Daniel et al. 2011). Recently, these kinases arose as a potential trigger of
autophagy during infection. Escherichia coli (ETEC) exploits host’s autophagic
machinery through the inhibition of mTOR pathway and ERK1/2 and AMPK
phosphorylation (Tang et al. 2014). Similarly, the peroxisome proliferator-
activated receptor-gamma coactivator 1α (PPARGC1A)-dependent activation of
AMPK inM. tuberculosis infection results on increased transcription of autophagy-
related genes via CCAAT/enhancer binding protein β (CEBPB). This activation
was also associated with increased mitochondrial respiration and biogenesis (Yang
et al. 2014). TLR 1/2 has been associated with the initiation of autophagic mech-
anisms during mycobacterial infections (Yuk et al. 2009). This was shown to be
mediated by the mycobacterial lipoprotein LqpH, which activates TLR1/2 inducing
a rapid and transient increase in intracellular calcium concentration leading to
AMPK activation, possibly through upstream activation of CaMKK. Furthermore,
AMPK activation was shown to be essential for autophagy, resulting in the phos-
phorylation of p38-MAPK (Shin et al. 2010). Similarly to LqpH, pore-forming
toxins (PFT) are bacterial virulence factors that have been implicated in the
prompting of autophagy, although the underlining mechanisms remain elusive
(Gonzalez et al. 2008). Kloft and colleagues observed that several PFT
(streptolysin O, Vibrio cholera cytolysin, Staphylococcus aureus α-toxin, and
Escherichia coli haemolysin A) cause a drop in intracellular ATP levels leading
to AMPK activation (Kloft et al. 2010). It has been hypothesized that the formation
of membrane pores leads to the activation of downstream targets, as the AMPK
signalling pathway, which may contribute for the maintenance of cellular
homeostasis.
Further studies suggest that AMPK signaling may regulate and facilitate the
intracellular replication of this pathogen. Although xenophagy may be presented as
an antibacterial mechanism, it is important to reckon that other evasion mechanisms
driven by a chronic activation of AMPK in the infected cells can be used by
invading bacteria, such as Salmonella, to subvert the immune response (Tattoli
et al. 2012). Likewise, Legionella pneumophila, the causative agent of Legion-
naires’ disease, is capable of inhibiting the phagosome-lysosome fusion, in order to
subvert host cell immune response (Horwitz 1983). Macrophage mitochondria and
endoplasmic reticulum-derived vesicles are recruited to the vicinity of the
phagosome within the first minutes of L. pneumophila infection (Tilney
et al. 2001). The consequent encapsulation of Legionella-containing phagosomes
increases the survival odds of this bacteria, since it prevents its fusion with
lysosomes or acidifying vesicles. This subservient mechanism clearly suggests
the utilization of mitochondria and other organelles for support in early stages of
infection. Francione et al. (2009) using a Dictyostelium discoideum model for
mitochondrial disease observed a faster growth and higher bacterial burden in
mitochondrial disease strains. AMPK activation may also be beneficial for
Helicobacter pylori and Neisseria meningitidis infections. These gram-negative
bacteria colonize the gastric mucosa causing several local distresses as gastritis,
gastric ulcers, or gastric cancer. AMPK activation during gastric epithelial cells
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(GEC) cell infection is induced by transforming growth factor-β (TGF-β)-activated
kinase 1 (TAK1), resulting in decreased apoptosis of GEC cells and consequent
bacterial survival (Lv et al. 2014). The decreased level of apoptosis originates
persistence of infection and GEC proliferation, contributing to the development
of carcinogenesis. Accordingly with these results, administration of compound
13, a novel α1-selective activator of AMPK, was shown to decrease H. pylori-
induced GEC apoptosis through reactive oxygen species (ROS) scavenging and
activation of the AMPK-heme oxygenase (HO-1) pathway (Zhao et al. 2015).
Similarly, activation and overexpression of AMPK improve human brain micro-
vascular endothelial cells (HBMECs) permeability after a challenge with lipopoly-
saccharide (LPS) through suppression of the induction of NAD(P)H oxidase-
derived ROS (Zhao et al. 2014). AMPK was activated at 24 h postinfection,
while PKB-Akt protein analysis showed dephosphorylation and thus inactivation
(Schubert-Unkmeir et al. 2007). In spite of being demonstrated that N. meningitidis
regulates gene transcription, translation, and cell metabolism, it is necessary to
understand the virulence factors involved.
12.3.2 Bacterial Host Immune Response: A Double-Edge
Sword Controlled by AMPK
Nutrient availability is an important factor when evaluating effector T cell function,
since their dysfunction can impair the appropriate responses that culminate with
pathogen elimination. Mice with T cell-specific deletion of AMPKα1 infected with
an overexpressing OVA Listeria monocytogenes showed a decreased number of
total CD4+ and CD8+ T cells at 7 days postinfection. Not only their numbers were
reduced as their effector function, since ex vivo stimulation of infected splenocytes
in the conditional KO mice displayed lower levels of IFNγ+ (Blagih et al. 2015).
This work highlights the importance of AMPK in allowing the proper function of T
cells in response to pathogens, which is ultimately connected to the metabolic
pathways established in these cells. ROS production is one of the hallmarks of
innate host response against intracellular pathogens. Concomitant administration of
the AMPK inhibitor compound C with LPS originated an impaired immune
response to endotoxemia via the decrease of nuclear-factor kB (NF-kB) activation
pathway. This was correlated with a decreased chemotaxis of macrophages and
neutrophils to the liver, with decreased ROS production and TNFα levels in the
serum (Guo et al. 2014). Furthermore, upon AMPK activation, neutrophils showed
an enhancement in E. coli and S. aureus uptake and consequent killing. These
observations were supported in vivo using murine models for peritonitis-induced
sepsis where metformin-treated mice were found to have fewer viable bacteria
(Park et al. 2013). In opposition, in tuberculosis (TB) patients, AMPK-expressing
neutrophils were shown to be able to secrete higher quantities of metalloproteinase-
8 (MMP-8), in a NF-kB-dependent fashion, leading to matrix destruction and
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collagen. This study demonstrated that AMPK activation has a role in the secretion
of MMP-8 contributing to lung immunopathology during M. tuberculosis infection
(Ong et al. 2015). In a very elegant work, Chakrabarti et al. showed that the
disruption of Drosophila flies gut homeostasis upon Pseudomonas entomophila
infection was caused by the impairment of barrier repair pathways. The mechanism
of subversion of gut immune response was mediated by an activation of AMPK-
Tuberous sclerosis complex (TSC) stress pathways, which are responsible for TOR
inhibition and consequent repression of host translation mechanisms. Ultimately,
this contributes to the entrance of infected cells in a quiescent state, more prone for
tissue repair but that also allows P. entomophila survival (Chakrabarti et al. 2012).
12.3.3 Modulation of Host AMPK as a Pharmacological
Approach to Target Bacterial Infection
Metformin treatment restricts the intracellular growth of multidrug-resistantMyco-
bacterium tuberculosis strains in THP-1 and human monocyte-derived macro-
phages through mitochondrial ROS induction. Moreover, metformin
administration ameliorates lung pathology and reduces chronic inflammation
while enhancing the efficacy of conventional anti-tuberculosis drugs (isoniazid
and ethionamide) in mice models of acute and chronic tuberculosis. In this retro-
spective study, metformin treatment was associated with improved control of
infection and decreased disease severity (Singhal et al. 2014). Moreover, adminis-
tration of metformin suppresses the inflammatory effects of LPS via induction of
activating transcription factor-3 (ATF-3) and AMPK activation. Thus, mice with
LPS-induced endotoxemia treated with metformin displayed lower levels of IL-6
and TNF-α, thus decreasing inflammation in vivo (Kim et al. 2014). Furthermore,
metformin-induced activation of AMPK inhibited the release of high mobility
group box 1 (HMGB1), a protein involved in severe sepsis. This inhibition origi-
nated the observed anti-inflammatory effect in LPS-treated RAW264.7 macro-
phages and in endotoxemic mice, characterized by decreased levels of IL-6,
TNF-α, IL-1β, prostaglandin E2 (PGE2), and nitric oxide (NO) (Tsoyi
et al. 2011). The activation of AMPK can also be obtained by treatment with
AICAR. Similarly, in vivo treatment with this drug resulted in decreased
lipoteichoic acid (LTA)-driven lung inflammation (Hoogendijk et al. 2013).
Using cecal ligation and puncture (CPL) as a model of sepsis, it was shown that
AICAR prevented CLP-induced liver and kidney damage. Additionally, AMPK
inhibition in hepatic and renal cells with compound c exacerbated cytokine pro-
duction and prevented autophagy, thus culminating in increased tissue injury
(Escobar et al. 2015). The role of a new bioactive lignan, sauchinone, in AMPK
modulation has been studied. The activation of LKB1-AMPK pathway by this anti-
inflammatory molecule has been shown to decrease liver toxicity through preven-
tion of iron accumulation (Kim et al. 2009). Recently, Jeong and colleagues
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explored the role of sauchinone-induced AMPK activation in macrophage phago-
cytosis (Jeong et al. 2014). The authors demonstrated that sauchinone increased
phosphorylation of AMPK and p38 MAPK, which correlated with increased E. coli
phagocytic uptake by macrophages in mice lungs.
12.4 Interaction Between AMPK and Parasites
12.4.1 Host–Parasite Nutrient Sensing
All the organisms have the ability to sense their surroundings in search for nutrients
through a variety of strategies that have evolved to suit the particular needs of each
living form. In particular, protozoan parasites need to adapt to more than one host to
survive and multiply. Therefore, a dynamic interplay between the host and the
parasite is necessary to efficiently coordinate the various parasite developmental
stages. The best example would be the maintenance of limited parasite density
inside the host or in a distinct host niche that will be responsible for initiating a
specific response by ensuring space and nutrients to the entire parasite community
(Mony and Matthews 2015; van Zandbergen et al. 2010). This is quite remarkable
in African trypanosomes, Trypanosoma brucei spp., where a morphological and
molecular alteration into a “slender” form without proliferative capacity is critical
to restrain parasitemia and also to have an efficient transmission to the insect host
(Gjini et al. 2010; Vassella et al. 1997; Vickerman 1985). Moreover, the confirmed
presence of programmed cell death (PCD) in parasites such as Tetrahymena
thermophila, Leishmania spp., Trypanosoma cruzi, Plasmodium spp., Trypanosome
brucei, Giardia lamblia, Dictyostelium discoideum, Trichomonas vaginalis,
Peridinium gatunense, and Blastocystis hominis (Al-Olayan et al. 2002; Ameisen
et al. 1995; Pollitt et al. 2011; Rousset and Roze 2007; Zangger et al. 2002) is
another mechanism to control parasite density. As a result, the premature death of
host or vectors is prevented and the right number of parasites are then able to
dampen the host immune system and avoid the limitation of nutrients and resources
(Ameisen et al. 1995; Reece et al. 2011). Thus, nutrient availability is a key factor
for parasite fitness during infection.
These mechanisms will ultimately ensure a physical space and a nutrient-rich
niche that support parasite survival and high growth rate, while maintaining the
viability of its host reservoir. During the evolutionary process, unicellular organ-
isms developed strategies to sense extracellular nutrients and intracellular metab-
olite concentrations since they are often exposed to relevant variations. Some
nutrient sensing pathways, as chemoreceptors and PII proteins in bacteria, MEP2
sensor, SPS pathway, and Snf3/Rgt2 sensors in fungi and PII proteins in plants, are
unique for these organisms. Such pathways respond to nitrogen, amino acids,
ribose, galactose, glucose, and ammonium fluctuations (Chantranupong
et al. 2015). Three important pathways, highly conserved from yeast to man, are
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responsible to sense different nutrient pools. These are general amino acid control
non-derepressible 2 (GCN2), TOR kinase and AMPK. Amino-acid levels are
sensed by GCN2 and mTOR, while glucose is regulated by mTOR and AMPK
and energetic fluctuations are uniquely controlled by AMPK (Chantranupong
et al. 2015). Thus, while host and parasites can actually share some nutrient sensors,
this section will focus only in AMPK.
12.4.2 AMPK in the Context of Parasite Infection:
Host–Parasite Nutrient Dynamics
The exquisite host–parasite interaction is the result of a coevolution network that
has been established continuously since the very first ancient association. The
parasite and host coevolution has been developed in parallel throughout time
although parasites possess an advantage due to their shorter generation time and
to the higher growth rate. To preserve its higher proliferative capacity, parasites
have to acquire nutrients from the host, its nutritional requirement being one of the
key features in the host–parasite interaction. Within host parasite this dynamic, a
nutrient competition is established between the manipulative parasite trying to
obtain usable energy and metabolites and the host attempting to sequester the
same precursors from the pathogen. The heavy metabolic pressure established
dictates the parasite auxotrophy to several nutrients, the host being the only viable
source for acquisition. Interestingly, parasites are auxotrophic for several amino
acids that are essential for the host. The nutritional pressure on extracellular and
intracellular parasites is differently exerted. Extracellular parasites can salvage the
nutrients directly from the extracellular fluids, while intracellular parasites need to
import nutrients across two or three host membrane systems. Indeed, intracellular
parasites need to gain access to nutrients present in the cytosol or inside the intra-
vacuolar structures where the threshold levels of amino acids do not match with the
high demands of these organisms for carbon, nitrogen, and energy to support its
high proliferative rate (Abu Kwaik and Bumann 2013). However, despite their
localization, parasites developed several strategies to acquire sufficient nutrients in
response to their biological needs. Plasmodium spp. (intracellular), T. brucei (extra-
cellular), and Leishmania spp. (intracellular) acquire nutrients from their hosts by
employing different transport proteins, named permeases, located inside their
plasma membrane. The nutrients imported from the host include hexoses, purines,
iron, polyamines, carboxylates, and amino acids. The different niches occupied by
these parasites in their hosts dictate ultimately the mode of nutrient acquisition
(Landfear 2011). As an example, during L. major amastigotes persistence in the
macrophage phagolysosomes, the parasite exploits the macrophage function on
extracellular matrix turnover and remodeling in terms of internalization and deg-
radation of glycosaminoglycans (hyaluronan). This mechanism constitutes another
process to exploit additional nutrients such as amino sugars as a carbon source. The
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dependency of Leishmania on a higher nutrient variety suggests a nutritional
diversity inside phagolysosomes that could ultimately represent an advantage to
colonize such harsh environment (Naderer et al. 2015). The response of the host
against the diversion of nutrients by the parasite is through the restriction of parasite
access to nutrient sources. Thus, the process of nutritional immunity limits the
availability of iron, zinc, and manganese from the invading pathogens (Crawford
and Wilson 2015). An iron-depleted niche is established during L. major infection
through the transporter NRAMP1 located at the phagolysosomal compartment.
Indeed, NRAMP1 mutation renders the host macrophages more susceptible to
Leishmania infections (Appelberg 2006; Forbes and Gros 2001). The strategies
developed by the host and parasite in terms of nutrients dynamic will impact the
infection outcome.
12.4.3 AMPK on the Core of Host–Parasite Metabolic
Coupling
The nutritional flow established within host–parasite communities will impact
the host metabolic background. Several reports have become to identify the
pathways involved in the metabolic manipulation of host metabolism required
for intracellular pathogen growth. Recent studies with Toxoplasma gondii
(MacRae et al. 2012), Trypanosoma brucei (Wang et al. 2008), Leishmania
spp. (Moreira et al. 2015a; Rabhi et al. 2012), Schistosoma mansoni (Wang
et al. 2008), and Plasmodium berghei (Li et al. 2008) have paved the way to
the understanding on the molecular mechanisms used by parasites to take advan-
tage of the nutritive host resources. At the core of these metabolic dynamic
interactions, AMPK was identified as having a crucial role to balance the
energetic status of the host with a positive or negative impact on parasite
survival. Nevertheless, the role of AMPK during the metabolic host–parasite
crosstalk still remains largely unexplored.
A microarray analysis performed on mice livers of experimental P. berghei
infection revealed significant variations within genes related to carbohydrate and
energetic metabolisms. This approach demonstrated an upregulation of gluconeo-
genesis pathways while glycolysis appears downregulated on liver extracts from
mice infected with P. berghei. Interestingly, these modifications were accompanied
by an increase in the energetic sensors, Prkaa2 (AMPKα) and Prkag2 (AMPKγ)
transcripts (Sales-Dias 2011). Analyzing AMPK translational levels will be impor-
tant to clarify the actual role during P. berghei liver stage infection. A potential role
of AMPK during an experimental model of cerebral malaria (ECM) was recently
suggested (Gordon et al. 2015). The mTOR inhibitor rapamycin protects against
ECM when administered within the first 4 days of infection. Rapamycin increased
survival, blocked the breakdown of the blood–brain barrier and brain hemorrhag-
ing, and decreased the influx of both CD4+ and CD8+ T cells into the brain and the
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accumulation of parasitized red blood cells in the brain. The impact of mTOR-
controlled metabolic pathways and the recent knowledge regarding the activation of
metabolic pathways in T cells upon antigen recognition led the authors to suggest a
possible impact of some metabolic pathways, such as AMPK, in the control of this
disease.
An intense inflammatory reaction accompanies infection with Trypanosoma
cruzi, the etiologic agent of Chagas disease. T. cruzi targets the adipose tissue
leading to a release of inflammatory cytokines as well as a decrease in adiponectin
and PPAR-γ contributing to the establishment of an inflammatory niche. Interest-
ingly, given that adiponectin activates AMPK, it was suggested that a
downregulation of the former could be a evasion mechanism to keep AMPK in
check and favor parasite growth (Nagajyothi et al. 2008). A recent work confirmed
a protective role for AMPK during T. cruzi infection (Caradonna et al. 2013). A
genome-wide RNA interference screen identified that a sustained AKT-mTORC1
pathway regulate intracellular T. cruzi growth. The maintenance of cellular
ATP/ADP ratios at higher levels provide a distinct advantage for the parasite-
limiting AMPK activity. Further, the acute silencing of AMPK catalytic (Prkaa1)
or the regulatory subunit (Prkab1) in vitro provides a more favorable growth
environment for intracellular T. cruzi. Although it has not been confirmed
in vivo, AMPK inhibition is suggested to contribute for T. cruzi survival.
Recently, we demonstrated that AMPK is, in contrast, crucial for the establish-
ment of a microenvironment more prone for L. infantum survival in macrophages
(Moreira et al. 2015a). Previous analysis on the transcriptomic signature of
L. major-infected macrophages revealed that carbohydrate and lipid metabolism
were among the most altered pathways during infection. Increased mRNA levels of
glucose transporters as well as key glycolytic enzymes encoding genes, such as
hexokinases (Hk), pyruvate kinase M2 (Pkm2), and lactate dehydrogenase a (Ldha),
were induced in the presence of live but not heat-killed L. major promastigotes.
L. major also induced a downregulation of a number of genes implicated in the
tricarboxylic acid (TCA) cycle and oxidative phosphorylation suggesting that
infected macrophages mainly rely on increased glycolytic flow for energy produc-
tion. On the other hand, L. major led to cholesterol and triglycerides accumulation
on infected macrophages by enhancing the expression of scavenger receptors
involved in the uptake of low-density lipoprotein (LDL), inhibiting cholesterol
efflux and increasing the synthesis of triacylglycerides (Rabhi et al. 2012). The
accumulation of lipid droplets in close proximity to parasitophorous vacuoles
advocates the former structure as a potential high-energy substrate source for the
intracellular parasite. We further observed that following L. infantum infection,
macrophages switch from an early glycolytic to an oxidative metabolism, in a
process requiring SIRT1 and LKB1/AMPK. In the absence of SIRT1 or LKB1,
infected macrophages are not able to induce AMPK activation leading to an
impairment of the metabolic switch. In that sense, AICAR-induced AMPK activa-
tion contributes to parasite survival while inhibition of AMPK using compound C
resulted in lower parasite numbers in vitro. This phenotype was further
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corroborated in vivo as shown by a significantly reduced parasite burden in mice
with a myeloid-specific AMPK deficiency (Moreira et al. 2015a).
Gastrointestinal (GI) nematodes also affect profoundly host metabolism. The
infection of CD11c-specific AMPKα–/– (DC-AMPK–/–) mice with the gastrointes-
tinal roundworm Nippostrongylus brasiliensis led to a dysregulation of Th2
immune response concomitantly with a failure to regenerate tissue damage medi-
ated by the pathogen. Imbalanced responses generated in DC AMPK–/– mice were
associated with increased Type-1 responses, greater numbers of Th17 cells, and
defects in the generation of alternatively activated macrophages. Therefore, AMPK
activity in myeloid cells was shown to regulate host protection against this GI
parasite (Nieves et al. 2014). The manipulation of AMPK activities by distinct
parasites are summarized in Fig. 12.3. Although still insufficient, these examples
highlight the strategies used by the parasites to explore host resources shedding
some light on cellular metabolic subversion mechanisms induced by microbe
infections within the host. In this context, the modulation of AMPK activity has
been put forward as a possible therapeutic target against parasitic diseases.
12.5 Conservation of the AMPK Machinery in Eukaryote
Pathogens
12.5.1 SNF1/AMPK Pathways in Parasites
The AMPK family of protein kinases is highly conserved among eukaryotes. This
protein has been extensively studied in mammals and yeast, where it was demon-
strated to have a huge similarity from a structural and functional point of view. The
conserved kinase family present in yeast and plants is denominated as sucrose
non-fermenting 1 (SNF1) and SNF1-related protein kinase 1 (SnRK1), respectively
(Hardie 2007; Polge and Thomas 2007). Genes encoding orthologues of the three
domains (α, β, and γ subunits) are described in all eukaryotic parasite species and
even in the primitive Giardia lamblia, which lacks mitochondria (Adam 2000;
Hardie et al. 2003). The exception is the obligate intracellular parasite
Encephalitozoon cuniculi that does not possess an identifiable AMPK orthologue
(Miranda-Saavedra et al. 2007).
SNF1 and SnRK1 homologs develop similar functions in what concerns the
surveillance of the metabolic status in response to nutrient and environmental stress
through the induction of catabolic processes and a general repression of anabolism.
Similarly to these organisms, some reports have defined the presence of AMPK/
SNF1 protein kinases in eukaryote parasites. The first evidence of the presence of
an SNF1 homologue in parasites was described in apicomplexa phylum for Plas-
modium falciparum (Bracchi et al. 1996). In this work, an SNF1 homologous gene
defined as PfKIN was found to be increased, at transcriptional level, in the game-
tocyte stage which is involved in the transmission and adaptation of the malaria
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Fig. 12.3 Host AMPK dictates parasite infection outcome. (a) In a context of malaria liver stage
infection, Plasmodium berghei modulates the transcriptional program of the host hepatocytes.
Within the host cells, P. berghei increases gluconeogenesis enzymes and Prkaa2 (AMPKα),
Prkag2 (AMPKγ) transcripts, decreasing in parallel the transcription of Pfk glycolytic enzyme.
At this stage, an increase of glucose levels is established generating a permissive niche for
sporozoites survival, which are highly dependent on glucose. (b) During Leishmania infantum
infection, the promastigote form induces a metabolic alteration toward a glycolytic environment
with a decrease of energetic (ATP/AMP) and redox status of the host. The increased AMP levels
triggers the activation of AMPK that will be phosphorylated by SIRT1-LKB1 pathway which, in
this context, is considered an AMPK upstream activator. Afterwards, a metabolic rearrangement
occurs through the increase of respiration and PGC-1α activation. At this point, the energetic and
redox pools are recovered leading ultimately to the parasite survival. (c) A detrimental effect of
AMPK was defined for Nippostrongylus brasiliensis persistence within the host. The specific
ablation of AMPK in dendritic cells deregulated the type 2 response establishing a type 1 through
the augmentation of Th17 cells. Simultaneously, the ability to alternatively activate macrophages
is dampened, concomitantly with the decrease capacity to regenerate tissue damage induced by the
pathogen. (d) AMPK in a context of T. cruzi infection has also a deleterious effect for the pathogen
survival and growth. Inside the host, trypomastigotes supports AKT-mTORC1 pathway activation
maintaining in parallel, a high energetic level that consequently ablates AMPK activity. Ulti-
mately, the established niche becomes permissive for the amastigotes survival and growth inside
the host. Pfk phosphofructokinase 1, ECAR extracellular acidification rate, OCR oxygen consump-
tion, SIRT1 silent mating type information regulation 2 homolog 1, LKB1 liver kinase B1, AMPK-p
AMP-activated protein kinase α-phosphorylated, PGC-1alpha peroxisome proliferator-activated
receptor gamma coactivator 1-alpha and mTORC1, mammalian target of rapamycin complex 1
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parasite from the human bloodstream to the mosquito midgut. The deduced protein
sequence of PfKIN contains all the characteristic sequence motifs of the eukaryotic
protein kinases including the ones involved in ATP-binding, substrate recognition,
and catalysis. The PfKIN catalytic domain shows 40% of homology with the SNF1
sequence from S. cerevisiae. It is important to underline that no significant amino
acid sequence similarities to any other proteins were found outside the catalytic
domain. This suggests that PfKIN can be modulated by other signals that differ
from the ones found in other eukaryotes (Bracchi et al. 1996). A systematic
functional analysis of protein kinases in P. berghei identified a SNF1/KIN protein.
This orthologue was shown to be relevant for sporozoite development, particularly
in the egression to the salivary gland of the mosquito Anopheles stephensi, acting as
a regulator of energy metabolism (Tewari et al. 2010). The existence of a SNF1/
AMPK orthologue was observed in Cryptosporidium parvum (Artz et al. 2011) that
lacks Krebs cycle and oxidative phosphorylation. In Eimeria acervulina, a putative
protein belonging to the SNF1 family was identified and correlated with invasion
and evasion mechanisms in chicken duodenal epithelial cells (Zhang et al. 2015).
Finally, still in the apicomplexa phylum, a potential AMPK homolog (ToxPK1) was
observed in Toxoplasma gondii genome with 58% identity to human AMPK alpha.
ToxPK1 gene was shown to be transiently expressed to upregulate glycogen
biosynthesis during the development of tachyzoites into bradyzoites (Ghosh
et al. 2012; Ng et al. 1995, 1997).
A comparative analysis of the kinomes of representative members of pathogenic
trypanosomatids, namely Trypanosoma brucei, Trypanosoma cruzi, and Leish-
mania major, have highlighted that AMPK homologues are relatively poorly
represented within trypanosomatid genomes as compared to humans. Yet, these
are predicted to be active (Parsons et al. 2005). In T. brucei, the fine-tuned control
of transient alteration from the “slender” (proliferative) to “stumpy” (quiescent)
forms is performed by intracellular signaling pathways triggered by the “stumpy
induction factor” (SIF). The slender state is retained until SIF accumulation reaches
threshold levels triggering the nutritional stress-like response, which leads to
concomitant repression of the “slender retainers” and activation of “stumpy
inducers.” This dynamic transition leads to cell cycle arrest and prepares the cell
for its next life cycle stage, in the insect, by reactivating mitochondrial functions
required for oxidative phosphorylation (Mony and Matthews 2015). A potential
role for AMPK in this developmental transition can be speculated. The signaling
components that drives stumpy formation evaluated in a genome-wide RNA inter-
ference library screen identified a AMPK/SNF1/KIN11 homologue. Interestingly,
the authors suggest that AMPK homologue, which acts as a SIF, could be a
potential inhibitor of trypanosomes TORC4 (Mony et al. 2014). TORC4 activity
is proposed to prevent stumpy formation, since the knockdown of TOR4 drove the
cells to develop features characteristic of stumpy forms (Barquilla et al. 2012).
TOR4 is one of the T. brucei TOR paralogues that retain the classical structure of
mTOR kinase domains, yet displaying new features not described in other TORs
(Barquilla et al. 2008). T. brucei procyclic forms are able to monitor glucose levels,
through the surface molecule expression of procyclins, which are crucial for the
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parasite survive in the tsetse fly vector (Clemmens et al. 2009). Procyclins are
glycoproteins that cover the surface of procyclic forms that are suspected to have a
protective role against the action of insect proteases (Acosta-Serrano et al. 2001).
Two major procyclin proteins EP and GPEET were found to be regulated by the
beta and gamma subunits (TbAMPK beta and TbAMPK gamma, respectively), since
the silencing of these genes leads to their upregulation. Interestingly, the latter
procyclin is highly expressed in glucose-deficient environment within tsetse fly.
Moreover, the localization of the scaffold beta subunit (glycosomes and flagellum)
suggests a central positioning between surface molecule expression and glycolysis
providing thus a molecular connection between these two mechanisms (Clemmens
et al. 2009).
It is important to stress out that the role of AMPK/SNF1 protein kinase family
are quite similar for all the organisms (extracellular or intracellular), playing a
central positioning in its most relevant pathways. The described AMPK/SNF1
homologues have been implicated in the parasite developmental stages that occur
within the same host or in different hosts in order to recover from a nutrition/
energetic depletion status. Parasites have to deal with different microenvironments
during proliferation and differentiation recurring to sensing mechanisms as the
AMPK/SNF1 protein kinases that will have definitely a huge impact on parasite
fitness.
12.5.2 SNF1/AMPK Pathways in Fungi
Over the past years, the incidence of fungal infections has increased in several
countries. Compared to bacteria, infections caused by fungi are less frequent;
nevertheless, their treatment is still complicated for systemic infections particularly
due to the close functional similarity between fungal cells and the host mammalian
cells (Navarro-Garcia et al. 2001). Human pathogenic fungi encounter a broad
range of stress conditions in their natural environment as well as in the host during
infection that challenge their ability to grow. The fungi ability to adapt to a variety
of conditions has contributed to the ubiquitous nature in the environment and to the
success of them as pathogens. In fact, adaptation to nutrient fluctuations is crucial
for survival. Human pathogenic fungi must adapt to oxidant, pH, or nutritional
stress, otherwise they are eliminated by the host defense system. Fungi survival,
both in the environment or within the human host, requires the activation of signal
transduction pathways that sense environmental or host stress cues (Hohmann
2002). During host nutritional deprivation, fungi pathogens are able to use alterna-
tive carbon sources, such mechanism being considered a virulence trait crucial to
adapt to stress conditions (Lorenz and Fink 2001). Therefore, it is not surprising that
genes that control several metabolic pathways may have a central role in fungal
virulence (Navarro-Garcia et al. 2001).
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12.5.3 Regulation and Function of Fungi SNF1 Protein
Kinase
Snf1 protein kinase was initially identified by a screening performed with the
budding yeast Saccharomyces cerevisiae (Celenza and Carlson 1986). Snf1 was
identified as the yeast homolog of the mammalian AMPK acting as an energy
sensor. This kinase, in fungi, is also able to reprogram the cellular metabolism
through the energetic balance which is essential to sustain cell metabolism and to
support the development of a stress response (Sampaio-Marques et al. 2014).
S. cerevisiae Snf1 is a serine/threonine protein kinase (α subunit) complexed with
other proteins, namely γ activating subunit Snf4 and β subunits Sip1, Sip2, or Gal83
depending on Snf1 localization (Celenza and Carlson 1989; Celenza et al. 1989;
Estruch et al. 1992; Vincent and Carlson 1999). AMPK/Snf1 activation in fungi
could be dependent or not on AMP/ATP cellular fluctuations. In the former, the
allosteric regulation by AMP is not crucial for Snf1 activation while in the latter
Snf1 function is regulated by cAMP-dependent protein kinase (PKA) (Ferretti
et al. 2012).
A crucial activity on glucose balance has been also attributed to Snf1 kinase.
This is of particular importance since glucose is one of the major carbon and energy
source for the eukaryotic cells. Under carbon stress conditions, fungal cells required
the activity of the Snf1 kinase in order to adapt to this harsh environment. Further-
more, Snf1 activity is requested for transcription of glucose repressed genes and
increases with aging, even when glucose is abundant (Ashrafi et al. 2000;
Hedbacker and Carlson 2008). Taken together, Snf1 allows cells to adapt to
limitations on glucose availability using instead alternative carbon sources, such
as sucrose, galactose and ethanol (Carlson 1999; Gancedo 1998). Additionally,
Snf1 is highly important in many other cellular stress conditions helping to establish
a response against sodium ion stress, heat shock, alkaline pH, and oxidative and
genotoxic stress (Hedbacker and Carlson 2008). Other crucial biological impact of
Snf1 has been described for glycogen, sterol, fatty acid biosynthesis, fatty acid-β
oxidation, peroxisome biogenesis, and ultimately in the fungi sporulation develop-
mental stage (Sanz 2003). The main functions of Snf1 kinase in pathogenic fungi
are resumed in Fig. 12.4.
12.5.4 SNF1 Protein Kinase in Pathogenic Fungi
In Candida spp., namely Candida glabrata, the importance of Snf1 kinase for the
regulation of nutrient sources availability was already demonstrated. Snf1 ablation
resulted in the loss of its capacity to utilize trehalose, which together with glucose
are the carbon sources preferentially used by this organism (Petter and Kwon-
Chung 1996). In the yeast Cryptococcus neoformans, a pathogenic fungus that
infects via respiratory tract, particularly immunocompromised individual
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(Buchanan and Murphy 1998; Hull and Heitman 2002; Mitchell and Perfect 1995),
the SNF1 abrogation leads to the incapacity to use alternative carbon sources such
as acetate, ethanol, and sucrose. Furthermore, an increase on sensitivity to anti-
fungal drugs such as amphotericin B and to nitrosative stress was also detected,
manifested particularly at the host temperature of 37 C (Hu et al. 2008; Yang
et al. 2010a). In other fungi species such as Aspergillus spp., the absence of SnfA1
(Snf1 homologue) causes a defect on glucose-depression mechanisms and impairs
Fig. 12.4 SNF1 protein kinase in pathogenic fungi. Snf1, AMPK homolog in fungi, functions as
an energy sensor and allows for a proper response and adaptation to environmental stress. This
kinase is activated during low ATP/AMP ratio and also by PKA, in an independent fashion. Snf1
activation allows the adaption to limitations on glucose availability and prompts the use of other
alternative carbon sources, like sucrose, galactose, and ethanol. Snf1 ablation results in metabolic
impairment and the loss of inability to use different carbon sources, with possible consequences in
fungi pathogenicity, namely, regarding susceptibility to antifungal therapy and cell wall constitu-
tion. Furthermore, in glucose deprivation conditions, Snf1 promotes transcription of FLO11 gene,
which encodes to a protein required for invasive growth and biofilms, thus impacting C. albicans
invasion and consequent pathogenicity. Snf1 is also responsible for the regulation of melanin
production by C. neoformans, which is an important cell wall-associated virulence factor. AMP
adenosine monophosphate, AMPK AMP-activated protein kinase, ATP adenosine triphosphate,
PKA cAMP-dependent protein kinase
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the pathogen growth under various carbon sources. Together, data from the
different pathogenic fungi suggest that Snf1 presents a conserved function in the
regulation of catabolic repression. In alignment with this conserved function that
allows the cells to adapt to adverse metabolic conditions, a role in fungus virulence
is also attributed to Snf1, which evidences a regulatory connection between carbon
source utilization and intracellular growth. In Candida albicans, an opportunistic
pathogen that is able to invade different tissues of immunocompromised individ-
uals causing disease, it was demonstrated that Snf1 is an essential protein.
C. albicans cells survival depends on the functionality of Snf1 kinase even in the
presence of glucose (Petter et al. 1997), which goes against what is observed in
S. cerevisiae, suggesting a central role for Snf1 in C. albicans. However, since
SNF1 is an essential gene, its functions in C. albicans are still few disclosed. In
S. cerevisiae, it was unveiled that Snf1 is able to transcriptionally regulate flocullin
(FLO11), which encodes to a protein required for invasive growth and biofilm
formation. In addition, Snf1 inhibits the function of Nrg1 and Nrg2, two negative
regulators of FLO11, in response to glucose depletion. This data suggests that
pseudohyphal growth and invasive growth depend on Snf1 activity (Kuchin
et al. 2002). Since SNF1 and NRG genes are sustained in C. albicans, it is
hypothesized that this regulatory mechanism is functionally conserved. Thus, in
this pathogenic fungus, Snf1 plays a role in the morphological transition from
yeast form to filamentous growth, a process that is vital for the pathogenicity of
C. albicans (Kuchin et al. 2002).
A role in C. neoformans virulence is also ascribed to Snf1. In this organism, the
link of Snf1 with virulence might be also in part associated with the production of
the pigment melanin, a cell wall-associated virulence factor, since snf1 mutant
strains presented reduced melanin production at 37 C (Hu et al. 2008). Melanin
production is regulated by the activity of the copper-containing polyphenolic
oxidase laccase, majority promoted by the LAC1 gene. LAC1 transcription is
enhanced by glucose starvation, yet by undisclosed mechanisms; nevertheless, it
is suggested that Snf1 participates in the LAC1 derepression by glucose depletion
(Yang et al. 2010a).
Adhesion capacity is another important feature for fungus pathogenicity because
it is able to mediate the interaction between colonies as well as host–pathogen
interactions (Ramsook et al. 2010). Concerning this pathogenicity feature, it was
demonstrated, in vitro, that SNF1 abrogation in C. neoformans impairs the cells
ability to adhere to agar in comparison with control strains (Yang et al. 2011).
Furthermore, the same study also demonstrated that snf1 mutant cells presented a
phonotype compared with cell wall defects, since they are sensitive to SDS and
Congo red (Yang et al. 2011). Thus, Snf1 apparently has also a contribution
concerning the modulation of the cell wall integrity that functions as essential
barrier to protect cells from harmful effects caused by the extreme conditions
frequently face by fungal cells (Bermejo et al. 2008; Levin 2005; Waterman
et al. 2007). Together, the data suggests that the observed cell wall impairment
observed in the absence of Snf1 might cause changes of the cellular surface
components such as glycoproteins which could lead to the loss of adhesion
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capacity; nevertheless, the adhesion regulation pathways in C. neoformans are yet
undisclosed.
The kinase Snf1 functions are well characterized in the yeast S. cerevisiae, a
model organism in which it was demonstrated that this kinase has a central
metabolic function. At the same regulation level, several studies in important
human pathogenic fungi showed that Snf1 homologs presented a conserved func-
tion, evidencing that this protein can be a potential antifungal target. More inter-
estingly, several observations point out Snf1 as a regulator of virulence factors as
well as a virulence factor. Concerning this aspect, Snf1 is able to modulate crucial
fungal pathogenic mechanisms, as above discussed; nevertheless and due to its
crucial role in the cells viability, new approaches must be developed in an attempt
to disclose the precise pathogenic mechanism regulated by Snf1. Together, all the
pieces of information highlighted that Snf1 might represent a promising alternative
target of interest to drug development.
12.6 Final Remarks
Host–pathogen interactions are highly dynamic processes where both compete to
acquire a myriad of essential nutrients, crucial to survive inside an infection niche.
Although it seems well established that pathogens manipulate host metabolism in
its own advantage, the preferred nutrient sources and the triggered metabolic
pathways are still to be completely understood. In this context, the manipulation
of host AMPK activity seems to be a valuable approach for controlling pathogen
burden and infection progression.
The positive or negative impact on host AMPK protein during an infection could
reflect the existence of distinct biological and nutritional needs for the distinct
pathogens. Overall, two main factors contribute for the different responses
observed concerning host AMPK modulation during infection. First, in vivo,
microbial pathogens can find distinct niche/cells with different nutritional/immu-
nological status. Secondly, an heterogeneity in host–pathogen interactions (various
pathogens subsets) could occur simultaneously within the same host tissue
reflecting disparate outcomes (Bumann 2015). We can then speculate that pathogen
survival will depend on the ability to sense and find the most permissive cells
without discarding the overall contribution of the different pathogen subsets within
the same tissue. This vast heterogeneity during in vivo infections set the nutrient
sensors, as AMPK, in a more privileged core to impact on the disease outcome.
Moreover, an additional diversity in terms of AMPK/SNF1 orthologues function
was described within parasites and fungal organisms. The particularities of each
parasite or fungus life cycle and the pressure exerted by the different hosts could
guide the evolutionary process of these orthologues in distinct branches of the
phylogenetic tree that could account ultimately for their variability inside these
organisms. In that sense, the parasite and fungal AMPK/SNF1 members could
participate in the intracellular sensing of the nutritional status of the host. Thus, a
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rearrangement of their metabolic pathways may occur in order to acquire the
sufficient amount of nutrients and energy from the host to survive. Nevertheless,
the role for AMPK/SNF1 orthologues during the infectious process still remains
uncomprehend.
The quite unexplored field of nutrient sensors open a new avenue to exploit
AMPK as a possible drug target against microbial pathogens. The design of new
drugs to activate or inhibit this kinase in the host during infection could be an
interesting domain to explore. In fact, there are drugs currently used to treat
metabolic diseases that could be considered an alternative approach to treat infec-
tious diseases. A classic example is metformin, which is able to activate AMPK
through mitochondria complex I inhibition that is currently the most common
treatment for diabetes type 2. Although due to the large variation described in
terms of niche/cells and the presence of various pathogen subsets during in vivo
infections, several concerns are being raised. The described disparities may account
for the unsuccessful treatment or resistance development found in conventional
therapeutics. The possible addition/synergy of AMPK activators or inhibitors to the
conventional treatment could represent a viable and important therapeutic alterna-
tive to overcome this infection issue. Despite the highly conservation among
eukaryotes, AMPK orthologues described in parasites and fungi could be also
explored as potential drug targets. To develop selective activators or inhibitors to
these orthologues, the homology to mammals should be low, although relevant
divergences in the catalytic domain or differences in the protein weight/conforma-
tion should be considered. As an example, we can speculate that PfKIN from
P. falciparum could be considered a promising drug target due to the fact that its
catalytic domain presents 40% of homology with the SNF1 sequence of
S. cerevisiae, and no significant amino acid sequence similarities to any other
proteins were found outside the catalytic domain. AMPK orthologues have been
more studied in Plasmodium; however, further work will be needed to characterize
and define this protein as a possible drug target as well as in other pathogens.
Overall, the nutritional status of the host and the infection outcome can
influence each other occupying the microbial pathogens a central position in
this dynamic balance. The hallmark of the host metabolic status and infection
outcome is the gut microbial communities, defined as microbiota, which is
currently considered a hot research topic. In a healthy state, they contribute
nutrients and energy to the host, and a balance is maintained with the host’s
metabolism and immune system. On the other side, intestinal dysbiosis can act as
a source of inflammation and in-fection and possible contributions to diabetes
mellitus and obesity (Flint et al. 2012).This striking regulation could be essential
to improve or trace new antimicrobial strategies through the modulation of host
metabolism.
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